cannabis international

A Resource For The Dietary And Medicinal Study And Use Of Cannabis




Origins of Cannabis International Foundation

By Dr. William Courtney

My childhood fascination with the microbiologic world was latter supported by my studies of organic and biochemistries which came together in my undergraduate degree in microbiology. With the 2004 Scientific American article on the “Brains Own Marijuana”, my scientific interests of a lifetime joined forces. I have been immersed in the experiences of thousands of my patients who use raw cannabis daily. First introduced to dry green leaf, then fresh green leaf and now with the addition of raw fully mature flowers, the whole plant is restored.

The central therapeutic paradigm of western medicine is the silver bullet, penicillin. Its single action is to block the synthesis of cell walls, which are unique to bacteria and therefore not directly harm the individual with pneumonia. The western medical mind has a very hard if not impossible time trying to understand the diverse actions of Cannabidiol.

medical effects of cannabis

While 10,000 year old cultural practices involve drying then heating cannabis to effect a nearly complete decarboxylation of THC-Acid into THC. The creation of massive amounts of THC is compounded by the introduction of a psychoactive side effect that has a 10 mg dose limitation secondary to CB1 receptor stimulation. Research conducted in Bethesda Maryland led to Patent 6,630,507 held by the United States of America since 2003 that teaches that the lack of psycho-activity in CBD allows doses that are 100-200 times greater than the tolerable dose of THC. The articulated “Effective oral human dosage schedule is 20 mg / kg body weight” requires a considerable amount of cannabis. The simplest approach is to consume the trichrome laden fully mature flower along with the 80-day leaf. Patient responses have exceeded any expectations.

Historically, dietary use of the entire raw cannabis plant brings us back in line with 34 million years of cannabis evolution. Lipid messenger molecules preceded cannabis by billions of years. The 4 billion year old development of lipid messenger molecules not only regulated resource management in the most primitive life forms, but were central in the earliest autocrine and paracrine modulation of cellular function. I believe autocrine cross talk was the necessary precedent to symbiotic, then multi-cellular life forms. Tissue specific or paracrine cluster regulation is the domain of the lipid messenger molecules and is the path to comprehending the incredible diversity of function that are only now beginning to be understood. While our perception / publication of these physiologic properties are new, the phenomenal beneficial affects were there yesterday, last year, if not hundreds of millions to billions of years ago.

I seek to consolidate the science regarding the essential nature of the phyto- cannabinoid contributions to health maintenance and restoration. That akin to Essential Fatty Acids and Essential Amino Acids, there needs to be Minimum Daily Requirements established to guide worldwide adoption of raw cannabis as the single most important dietary element.

About William Courtney, MD

Dr. William L. Courtney has an extensive medical education that began with a Bachelor of Science in Microbiology from the University of Michigan. He also received his Doctor of Medicine from Wayne State University, and Interned for Residency in Psychiatry at California Pacific Medical Center and went on to earned his Post Doctorate in Forensic Examination and Forensic Medicine. Dr. Courtney is currently a member of American Academy of Cannabinoid Medicine, the International Cannabinoid Research Society, the International Association of Cannabis as Medicine, and the Society of Clinical Cannabis. Dr. Courtney has also been teaching Continuing Medical Education (CME) courses in clinical cannabis.

His area of special interest is in the dietary uses of cannabis to achieve 250 to 500 mg of cannabinoid acids, which he considers as a conditionally essential nutrient in the diet of individuals from the 4th decade on. He has presented on high dose non-psychoactive dietary uses at Cannabis Therapeutics in Rhode Island April 2010, the Institute of Molecular Psychiatry at the University of Bonn in June 2010, the Institute for Advanced Studies at The Hebrew University of Jerusalem in November 2010, and the International Cannabinoid Research Society conference in Chicago in July 2011.

Dr. Courtney is Vice President of the Association Luxembourgeoise des Methodes Preventives, an ambulatory care facility in Luxembourg utilizing dietary unheated cannabis. He is working with dispensaries interested in providing high dose raw / juiced cannabis to seriously ill medical marijuana patients, and is also working to establish analytic / medical laboratories in Mendocino and Humboldt Counties, California.

About Kristen Peskuski

Kristen Peskuski is a patient and researcher, who has used fresh cannabis leaf to put her Systemic Lupus, Rheumatoid Arthritis, Endometriosis and numerous other conditions into a sustained remission. She has a background in experimental research design and statistics, which helps her bridge the gap between patients, physicians, and researchers.

Kristen has presented her case study at the International Cannabinoid Research Society (ICRS), the International Cannabis As Medicine Society, Patient’s Out of Time, 420 University, in Bonn, Germany at The Endocannabinoid System: From Physiology to Pathophysiology, and in Israel this November at a conference held jointly by The Institute for Advanced Studies and the Israel Science Foundation. Her paper on the non-psychoactive effects of fresh, juiced cannabis flower and leaf was part of the ICRS symposium in Sweden last summer. This summer, she will be presenting a paper on cannabis use in pregnancy at the ICRS symposium in Illinois and at the International Cannabis As Medicine conference in Germany.

Kristen is the co-founder of Cannabis International, which is working to reverse the United Nation’s Convention One Treaty, in order to allow people access to cannabis worldwide. She is heading up the experimental research design department in Ettelbruck, Luxembourg, working with the Association Luxembourgeoise des Methodes Preventives. In addition, Kristen is reporting for O’Shaughnessy’s: The Journal of Cannabis In Clinical Practice. She is currently working on an extensive study of heavy cannabis usage and mother’s experiences with pregnancy, breastfeeding, and motherhood.